Published in Hypertension on December 01, 2000
Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle. Nutr Metab (Lond) (2004) 2.13
Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health (2004) 2.00
Association of Uric Acid With Vascular Stiffness in the Framingham Heart Study. Am J Hypertens (2014) 1.48
Serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetes. Cardiovasc Diabetol (2011) 1.45
The prevalence of hyperuricemia in China: a meta-analysis. BMC Public Health (2011) 1.25
Serum uric acid is associated with carotid plaques: the National Heart, Lung, and Blood Institute Family Heart Study. J Rheumatol (2009) 1.11
Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease? Br J Clin Pharmacol (2006) 1.09
Hydrogen peroxide regulates extracellular superoxide dismutase activity and expression in neonatal pulmonary hypertension. Antioxid Redox Signal (2011) 1.05
Uric acid is an independent predictor of arterial stiffness in hypertensive patients. Heart Vessels (2009) 1.03
Xanthine oxidoreductase depletion induces renal interstitial fibrosis through aberrant lipid and purine accumulation in renal tubules. Hypertension (2009) 0.93
Association between serum uric acid levels and cardiovascular disease in middle-aged and elderly Chinese individuals. BMC Cardiovasc Disord (2014) 0.90
Serum uric acid and 1-h postload glucose in essential hypertension. Diabetes Care (2011) 0.90
Relationship between serum uric Acid and bone mineral density in the general population and in rats with experimental hyperuricemia. J Bone Miner Res (2015) 0.88
Risk of macrovascular disease stratified by stage of chronic kidney disease in type 2 diabetic patients: critical level of the estimated glomerular filtration rate and the significance of hyperuricemia. Clin Exp Nephrol (2011) 0.88
The potential for xanthine oxidase inhibition in the prevention and treatment of cardiovascular and cerebrovascular disease. Cardiovasc Psychiatry Neurol (2009) 0.86
Uric acid levels predict future blood pressure and new onset hypertension in the general Japanese population. J Hum Hypertens (2014) 0.86
Long-term effects of L- and N-type calcium channel blocker on uric acid levels and left atrial volume in hypertensive patients. Heart Vessels (2016) 0.85
Severity of gouty arthritis is associated with Q-wave myocardial infarction: a large-scale, cross-sectional study. Clin Rheumatol (2006) 0.85
Hyperuricemia, Cardiovascular Disease, and Hypertension. Pulse (Basel) (2016) 0.84
Relationship Between Hyperuricemia and Cardiovascular Disease Risk Factors in a Chinese Population: A Cross-Sectional Study. Med Sci Monit (2015) 0.84
Deficiency of 5-hydroxyisourate hydrolase causes hepatomegaly and hepatocellular carcinoma in mice. Proc Natl Acad Sci U S A (2010) 0.84
Serum levels of uric acid and diabetes mellitus influence survival after surgery for primary hyperparathyroidism: a prospective cohort study. World J Surg (2007) 0.82
Clinical value of serum uric Acid in patients with suspected coronary artery disease. Korean J Intern Med (2010) 0.82
Uric acid, hypertension, and chronic kidney disease among Alaska Eskimos: the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study. J Clin Hypertens (Greenwich) (2012) 0.81
Uric acid level has a U-shaped association with loss of kidney function in healthy people: a prospective cohort study. PLoS One (2015) 0.81
Allopurinol is an independent determinant of improved arterial stiffness in chronic kidney disease: a cross-sectional study. PLoS One (2014) 0.81
Gout and Risk of Myocardial Infarction: A Systematic Review and Meta-Analysis of Cohort Studies. PLoS One (2015) 0.80
The association between hyperuricemia and betel nut chewing in Taiwanese men: a cross-sectional study. BMC Public Health (2013) 0.80
Association of renal manifestations with serum uric acid in Korean adults with normal uric acid levels. J Korean Med Sci (2010) 0.80
Association of Serum Uric Acid with Cardiovascular Disease in Taiwanese Patients with Primary Hypertension. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2015) 0.80
Serum uric Acid is not an independent risk factor for premature coronary artery disease. Cardiorenal Med (2013) 0.80
Serum Uric Acid Relation for Hearing Threshold Shift. Clin Exp Otorhinolaryngol (2016) 0.80
The relationship between serum levels of uric acid and prognosis of infection in critically ill patients. World J Emerg Med (2012) 0.79
High Uric Acid Induces Insulin Resistance in Cardiomyocytes In Vitro and In Vivo. PLoS One (2016) 0.79
Different pathomechanisms of essential and obesity-associated hypertension in adolescents. Pediatr Nephrol (2006) 0.79
Combination of uric acid and NT-ProBNP: a more useful prognostic marker for short-term clinical outcomes in patients with acute heart failure. Korean J Intern Med (2010) 0.79
Uric acid is a strong independent predictor of renal dysfunction in patients with rheumatoid arthritis. Arthritis Res Ther (2009) 0.79
Hyperuricemia is independently associated with endothelial dysfunction in postmenopausal women but not in premenopausal women. BMJ Open (2013) 0.79
Comparison of the Renoprotective Effect of Febuxostat for the Treatment of Hyperuricemia between Patients with and without Type 2 Diabetes Mellitus: A Retrospective Observational Study. Intern Med (2016) 0.79
Association between serum uric acid and bone health in general population: a large and multicentre study. Oncotarget (2015) 0.78
Association of serum uric acid with 2-hour postload glucose in Chinese with impaired fasting plasma glucose and/or HbA1c. PLoS One (2013) 0.78
Rationale and design of a multicenter randomized study for evaluating vascular function under uric acid control using the xanthine oxidase inhibitor, febuxostat: the PRIZE study. Cardiovasc Diabetol (2016) 0.78
Modifiable risk factors for increased arterial stiffness in outpatient nephrology. PLoS One (2015) 0.77
Uric Acid Levels in Normotensive Children of Hypertensive Parents. Int J Chronic Dis (2015) 0.76
Relationship between red cell distribution width and serum uric acid in patients with untreated essential hypertension. Sci Rep (2014) 0.76
Hyperuricemia and uncontrolled hypertension in treated hypertensive patients: K-MetS Study. Medicine (Baltimore) (2016) 0.75
Serum Uric Acid and Renal Transplantation Outcomes: At Least 3-Year Post-transplant Retrospective Multivariate Analysis. PLoS One (2015) 0.75
Longitudinal Study of Serum Uric Acid, Nutritional Status, and Mortality in Maintenance Hemodialysis Patients. Clin J Am Soc Nephrol (2016) 0.75
Association between xanthine dehydrogenase tag single nucleotide polymorphisms and essential hypertension. Mol Med Rep (2015) 0.75
Relation of uric acid levels to aortic root dilatation in hypertensive patients with and without metabolic syndrome. J Zhejiang Univ Sci B (2010) 0.75
Hyperuricemia: An Early Marker for Severity of Illness in Sepsis. Int J Nephrol (2015) 0.75
Development of Therapeutic Chimeric Uricase by Exon Replacement/Restoration and Site-Directed Mutagenesis. Int J Mol Sci (2016) 0.75
Role of ankle-brachial pressure index as a predictor of coronary artery disease severity in patients with diabetes mellitus. Can J Cardiol (2009) 0.75
Asymptomatic hyperuricemia is a strong risk factor for resistant hypertension in elderly subjects from general population. Biomed Pharmacother (2016) 0.75
Benefits of pomegranate (Punica granatum Linn) fruit extracts to weight changes, total protein, and uric acid in white rats (Rattus norvegicus) as an animal model of acute renal failure. Vet World (2016) 0.75
Role of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic Steatohepatitis. Mediators Inflamm (2016) 0.75
The association between shift work and hyperuricemia in steelmaking male workers. Ann Occup Environ Med (2014) 0.75
High-sensitivity C-reactive protein and mean platelet volume in paediatric hypertension. Pediatr Nephrol (2010) 0.75
Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation (1990) 3.88
Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension (1994) 3.79
Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation (2001) 3.14
Left ventricular hypertrophy as an independent predictor of acute cerebrovascular events in essential hypertension. Circulation (2001) 2.10
Ambulatory pulse pressure: a potent predictor of total cardiovascular risk in hypertension. Hypertension (1998) 1.99
Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Diabetes (1983) 1.86
Reversibility of unawareness of hypoglycemia in patients with insulinomas. N Engl J Med (1993) 1.83
Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation (1998) 1.83
Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension (2000) 1.81
Is the prevalence of Addison's disease underestimated? J Clin Endocrinol Metab (1999) 1.78
Blunted nocturnal fall in blood pressure in hypertensive women with future cardiovascular morbid events. Circulation (1993) 1.71
Levels of adrenocortical autoantibodies correlate with the degree of adrenal dysfunction in subjects with preclinical Addison's disease. J Clin Endocrinol Metab (1998) 1.68
Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass. J Am Coll Cardiol (1995) 1.65
Etiological diagnosis of primary adrenal insufficiency using an original flowchart of immune and biochemical markers. J Clin Endocrinol Metab (1998) 1.63
Abnormal pancreatic alpha-cell function in bacterial infections. N Engl J Med (1973) 1.62
Low dose (1 microg) ACTH test in the evaluation of adrenal dysfunction in pre-clinical Addison's disease. Clin Endocrinol (Oxf) (2000) 1.60
Association of MHC Class I chain-related A (MIC-A) gene polymorphism with Type I diabetes. Diabetologia (2000) 1.53
Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis (2004) 1.53
Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension. J Am Coll Cardiol (1998) 1.47
Effects of the short-acting insulin analog [Lys(B28),Pro(B29)] on postprandial blood glucose control in IDDM. Diabetes Care (1996) 1.46
Microsatellite polymorphism of the MHC class I chain-related (MIC-A and MIC-B) genes marks the risk for autoimmune Addison's disease. J Clin Endocrinol Metab (1999) 1.45
Cardiovascular response to exercise in diabetic patients: influence of autonomic neuropathy of different severity. Diabetologia (1995) 1.42
Home ambulatory blood pressure readings do not differ from clinic readings taken at the same time of day. J Hum Hypertens (1988) 1.39
A reliable and reproducible test for adequate glucose counterregulation in type I diabetes mellitus. Diabetes (1984) 1.39
Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double-blind, randomized trial. J Clin Endocrinol Metab (2004) 1.39
Calcium antagonists and cardiovascular risk in patients with hypertension and Type 2 diabetes mellitus: evidence from the PIUMA Study. Progetto Ipertensione Umbria Monitoraggio Ambulatoriale. Diabetes Nutr Metab (1999) 1.39
Blood pressure rise and ischaemic stroke. Lancet (1995) 1.38
Improved electrocardiographic diagnosis of left ventricular hypertrophy. Am J Cardiol (1994) 1.35
Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans. J Clin Invest (1993) 1.35
Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature. Endocr Relat Cancer (2006) 1.33
Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes. Diabetologia (2005) 1.29
Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production. Diabetes (1994) 1.29
Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy. Am J Cardiol (1996) 1.24
Effects of whole-body vibration exercise on the endocrine system of healthy men. J Endocrinol Invest (2004) 1.23
Different prognostic impact of 24-hour mean blood pressure and pulse pressure on stroke and coronary artery disease in essential hypertension. Circulation (2001) 1.22
Mechanisms of glucagon secretion during insulin-induced hypoglycemia in man. Role of the beta cell and arterial hyperinsulinemia. J Clin Invest (1984) 1.21
Erectile dysfunction in type 1 and type 2 diabetics in Italy. On behalf of Gruppo Italiano Studio Deficit Erettile nei Diabetici. Int J Epidemiol (2000) 1.18
Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study. Diabetes Metab Res Rev (2005) 1.18
White coat hypertension and white coat effect. Similarities and differences. Am J Hypertens (1995) 1.17
A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial. Diabet Med (2005) 1.17
A multicenter study on the prevalence of diabetic neuropathy in Italy. Italian Diabetic Neuropathy Committee. Diabetes Care (1997) 1.17
The dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus: magnitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity. Diabetologia (1991) 1.16
Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension. Circulation (1999) 1.15
Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series. J Clin Endocrinol Metab (2005) 1.15
High diagnostic accuracy for idiopathic Addison's disease with a sensitive radiobinding assay for autoantibodies against recombinant human 21-hydroxylase. J Clin Endocrinol Metab (1995) 1.14
X-linked adrenoleukodystrophy is a frequent cause of idiopathic Addison's disease in young adult male patients. J Clin Endocrinol Metab (1996) 1.14
Demonstration of a dawn phenomenon in normal human volunteers. Diabetes (1984) 1.10
Short daily hemodialysis: blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients. Am J Kidney Dis (2001) 1.06
Clinical impact of various geometric models for calculation of echocardiographic left ventricular mass. J Hypertens (1998) 1.06
Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici. Diabetes Care (1998) 1.05
Pancreatic alpha-cell function in trauma. JAMA (1974) 1.05
High-normal serum creatinine concentration is a predictor of cardiovascular risk in essential hypertension. Arch Intern Med (2001) 1.05
Association between persistent pressure overload and ventricular arrhythmias in essential hypertension. Hypertension (1996) 1.02
Prognostic significance of the white coat effect. Hypertension (1997) 1.02
Biochemical and molecular characterization of the novel BRAF(V599Ins) mutation detected in a classic papillary thyroid carcinoma. Oncogene (2006) 1.02
Osteopenia associated with non-insulin-dependent diabetes mellitus: what are the causes? Diabetes Res Clin Pract (1994) 1.01
Blood rheology in men with essential hypertension and capillary rarefaction. J Hum Hypertens (2002) 1.01
Modification of glycosylated haemoglobin concentration during artificial endocrine pancreas treatment of diabetics. Evidence for a short-term effect on HbA 1 (a+b+c) levels. Diabetologia (1980) 1.01
Impaired flow-mediated vasoactivity during post-prandial phase in young healthy men. Atherosclerosis (2000) 1.00
Effects of fenofibrate on endothelial function and cell adhesion molecules during post-prandial lipemia in hypertriglyceridemia. J Clin Pharm Ther (2003) 1.00
Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM. Diabetes (1997) 1.00